Artículos por temáticas

Asymmetric dynamic center-of-pressure in Parkinson's disease

Shin C, Ahn TB.

J Neurol Sci. 2020 Jan 15;408:116559. doi: 10.1016/j.jns.2019.116559. Epub 2019 Nov 1.

Sensation of TRPV1 via 5-hydroxytryptamine signaling modulates pain hypersensitivity in a 6-hydroxydopamine induced mice model of Parkinson's disease

Li M, Zhu M, Xu Q, Ding F, Tian Y, Zhang M.

Biochem Biophys Res Commun. 2020 Jan 22;521(4):868-873. doi: 10.1016/j.bbrc.2019.10.204. Epub 2019 Nov 7.

Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy

Sakakibara S, Hashimoto R, Katayama T, Kenjyo M, Yokokawa Y, Saito Y, Hirakawa A, Ito M, Nakamura T, Hara K, Hashizume A, Aiba I, Inukai A, Katsuno M.

J Parkinsons Dis. 2020;10(1):123-130. doi: 10.3233/JPD-191710.

The deficiency of NRSF/REST enhances the pro-inflammatory function of astrocytes in a model of Parkinson's disease

Li H, Liu Z, Wu Y, Chen Y, Wang J, Wang Z, Huang D, Wang M, Yu M, Fei J, Huang F.

Biochim Biophys Acta Mol Basis Dis. 2020 Jan 1;1866(1):165590. doi: 10.1016/j.bbadis.2019.165590. Epub 2019 Nov 7.

Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study

Chatterjee K, Roy A, Banerjee R, Choudhury S, Mondal B, Halder S, Basu P, Shubham S, Dey S, Kumar H.

J Neuroimmunol. 2020 Jan 15;338:577089. doi: 10.1016/j.jneuroim.2019.577089. Epub 2019 Oct 25.

An EEG marker of reward processing is diminished in Parkinson's disease

Brown DR, Richardson SP, Cavanagh JF.

Brain Res. 2020 Jan 15;1727:146541. doi: 10.1016/j.brainres.2019.146541. Epub 2019 Nov 5.

Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: The role of cannabinoid and opioid receptors

Binda KH, Real CC, Ferreira AFF, Britto LR, Chacur M.

Brain Res. 2020 Jan 15;1727:146521. doi: 10.1016/j.brainres.2019.146521. Epub 2019 Nov 4.

Unilateral Pseudo-Orthostatic Tremor Provoked by a Remote Limb Movement in Parkinson's Disease.

Yoo SW, Heo Y, Kim JS, Lee KS.

J Mov Disord. 2020 Jan;13(1):69-71. doi: 10.14802/jmd.19056. Epub 2019 Nov 8. No abstract available.

A meta-analytic review of prospection deficits in Parkinson's disease

Coundouris SP, Terrett G, Laakso L, Schweitzer D, Kneebone A, Rendell PG, Henry JD.

Neurosci Biobehav Rev. 2020 Jan;108:34-47. doi: 10.1016/j.neubiorev.2019.10.016. Epub 2019 Nov 1.

Systemic activation of Nrf2 pathway in Parkinson's disease

Petrillo S, Schirinzi T, Di Lazzaro G, D'Amico J, Colona VL, Bertini E, Pierantozzi M, Mari L, Mercuri NB, Piemonte F, Pisani A.

Mov Disord. 2020 Jan;35(1):180-184. doi: 10.1002/mds.27878. Epub 2019 Nov 4.

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK.

Mov Disord. 2020 Jan;35(1):20-33. doi: 10.1002/mds.27874. Epub 2019 Nov 4.

Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease

Hasuike Y, Endo T, Koroyasu M, Matsui M, Mori C, Yamadera M, Fujimura H, Sakoda S.

Med Hypotheses. 2020 Jan;134:109436. doi: 10.1016/j.mehy.2019.109436. Epub 2019 Oct 15.

Hash Transformation and Machine Learning-Based Decision-Making Classifier Improved the Accuracy Rate of Automated Parkinson's Disease Screening.

Yang TL, Lin CH, Chen WL, Lin HY, Su CS, Liang CK.

IEEE Trans Neural Syst Rehabil Eng. 2020 Jan;28(1):72-82. doi: 10.1109/TNSRE.2019.2950143. Epub 2019 Oct 29.

Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: A meta-analysis.

Zhang Y, Chen J, Xu C, Feng J, Li J.

Neurosci Lett. 2020 Jan 1;714:134544. doi: 10.1016/j.neulet.2019.134544. Epub 2019 Oct 28.

Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.

Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, Yang H, Lu L.

Brain Behav Immun. 2020 Jan;83:214-225. doi: 10.1016/j.bbi.2019.10.015. Epub 2019 Oct 25.